A leaked CDC-backed 2025–2026 COVID-19 vaccine effectiveness study is drawing serious scrutiny after revealing that its dozens of authors from the CDC, Westat, Kaiser Permanente, Columbia University, Indiana University, the University of Colorado, and other major institutions claimed the latest COVID shot provided substantial “additional protection” while failing to properly account for the most fundamental scientific variable of all: whether participants were already protected by prior COVID infections, previous vaccine doses, or both.
The claimed “benefit” was that the updated vaccine independently reduced serious COVID-related medical visits by roughly half.
But the study design makes that impossible to determine.
In plain English, this is like claiming a new bulletproof vest saved lives without knowing whether the people wearing it were already wearing armour beforehand.
Because the study failed to properly measure preexisting immunity, it is not possible to know whether the reported protection came from the 2025–2026 vaccine itself, prior infections, older vaccines, or hybrid immunity, making the paper’s central public-facing claim fundamentally confounded.
The manuscript was first made public by physician and Substack author Jeremy Faust, who published the study on Monday through Inside Medicine after reporting that CDC leadership blocked its publication in the agency’s Morbidity and Mortality Weekly Report (MMWR).
Follow us on Instagram @realjonfleetwood & Twitter/X @JonMFleetwood.
If you value this reporting, consider upgrading to a paid subscription.
For advertising & sponsorship opportunities, contact us by clicking below.
Headline Claims Push ‘Additional Protection’
The leaked study’s Key Points section prominently states:
“2025-2026 COVID-19 vaccines were associated with additional protection against medically attended COVID-19 beyond an individuals’ existing immunity.”
Researchers reported:
50% effectiveness against emergency department or urgent care visits
55% effectiveness against hospitalization
These figures were widely framed as evidence that the updated shots provided meaningful real-world benefit.
Buried Admission Undermines Central Claim
However, on page 13, the authors quietly acknowledge:
“Analyses did not account for previous SARS-CoV-2 infection or COVID-19 vaccination…”
This means the study did not control for:
Prior natural immunity from past COVID infections
Previous monovalent shots
Bivalent shots
2023–2024 boosters
2024–2025 boosters
Researchers compared people who got the latest shot against people who did not—without determining what preexisting immunity either group already possessed.
That means the study cannot tell whether the reported protection came from the new 2025–2026 shot itself, lingering immunity from prior infections or older vaccines, or some combination of all of them—making its headline “benefit” claim impossible to isolate with certainty.
The Paper’s Own Contradiction
Despite acknowledging this limitation, the authors still conclude:
“Receipt of 2025-2026 COVID-19 vaccination provided additional protection…”
Yet without separating prior immunity variables, the claimed benefit cannot be cleanly attributed to the 2025–2026 vaccine itself.
Positive Messaging Front-Loaded, Caveats Buried
The structure of the paper places:
Strong efficacy claims in the title, abstract, and key points
Major confounding limitations deep in the discussion section
This creates a misleading public narrative where most readers, journalists, and policymakers are likely to see the positive headline figures without understanding the severe methodological caveats.
Authors & Institutional Affiliations Behind the Leaked Study
The manuscript was authored by a large network of federal officials, contractors, academic researchers, and major healthcare system investigators spanning the CDC, Westat, Kaiser Permanente, Columbia University, Indiana University, University of Colorado, and other major institutions:
Ryan E. Wiegand, PhD — CDC National Center for Immunization and Respiratory Diseases
Sean Chickery, DHSc — Westat, Bethesda, Maryland
Duck-Hye Yang, PhD — Westat
Sarah W. Ball, ScD — CDC
Malini B. DeSilva, MD, MPH — CDC
Kristin Dascomb, MD, PhD — Intermountain Health, Utah
Stephanie A. Irving, MHS — Kaiser Permanente Center for Health Research, Oregon
Karthik Natarajan, PhD — Columbia University Irving Medical Center
Nicola P. Klein, MD, PhD — Kaiser Permanente Northern California Vaccine Study Center
Shaun J. Grannis, MD — Regenstrief Institute / Indiana University
Toan C. Ong, PhD — University of Colorado Anschutz Medical Campus
Elizabeth A.K. Rowley, DrPH — Westat
Adam Yates, PhD — Westat
Yan Zhuang, PhD — Westat
Sarah Wilson, MPH — Westat
Charlene E. McEvoy, MD — HealthPartners Institute
Inih J. Essien, OD — HealthPartners Institute
Omobosola O. Akinsete, MBBS, MPH — HealthPartners Institute
Allison L. Naleway, PhD — Kaiser Permanente Center for Health Research
Padma Koppolu, MPH — Kaiser Permanente Center for Health Research
Ousseny Zerbo, PhD — Kaiser Permanente Northern California
John R. Hansen, MPH — Kaiser Permanente Northern California
Karen B. Jacobson, MD, MPH — Kaiser Permanente Northern California
Lawrence Block, MPH — Kaiser Permanente Northern California
Brian E. Dixon, PhD — Regenstrief Institute / Indiana University
Thomas Duszynski, PhD — Indiana University
Colin Rogerson, MD, MPH — Indiana University
Michelle A. Barron, MD — University of Colorado
Catia Chavez, MPH — University of Colorado
Josephine Mak, MPH — CDC
Allison Avrich Ciesla, PhD — CDC / Eagle Health Analytics
Monica Godfrey, MPH — CDC
Amber Kautz, PhD — CDC / General Dynamics Information Technology
Morgan Najdowski, MPH — CDC / Eagle Health Analytics
Ruth Link-Gelles, PhD, MPH — CDC / U.S. Public Health Service
Jennifer DeCuir, MD, PhD — CDC
Amanda B. Payne, PhD, MPH — CDC
Despite their combined scientific credentials, institutional prestige, and access to advanced epidemiological expertise, these researchers collectively attached their names to a study that publicly implied the 2025–2026 COVID shot independently provided substantial “additional protection,” while concealing in the page-13 fine print that they failed to control for prior infections and prior vaccination history—the very variables required to determine whether the new shot itself provided any measurable independent benefit at all.
For many observers, this is not a minor oversight.
It represents a profound scientific and ethical failure.
Dozens of federally connected scientists, academic researchers, and major healthcare officials used the authority of their institutions to advance a headline conclusion that could easily mislead policymakers, physicians, journalists, and the public.
All while burying methodological omissions so severe that the study’s central effectiveness claim becomes fundamentally incapable of isolating the true source of the reported protection.
Dr. Richard Bartlett, a thirty-year emergency room director, called the omission “mind-blowing.”
He told this website:
“It’s mind-blowing that all of the so-called ‘experts’ who authored this paper refused to include prior infection and prior vaccination status in their analysis. Those are among the most fundamental variables necessary to determine where immunity is actually coming from. When researchers omit factors this critical, it feels purposeful and deceptive. The American people deserve transparent, scientifically rigorous research—not headline claims built on methodology that cannot clearly determine what is actually providing the protection.”
Bottom Line
The leaked CDC-backed 2025–2026 COVID vaccine paper used the authority of federal agencies, elite universities, healthcare systems, and dozens of credentialed researchers to promote headline claims that the latest shot delivered 50–55% “additional protection,” while burying the critical admission that prior infections and prior vaccination history were never properly accounted for.
Because the study failed to control for the very sources of immunity necessary to isolate the new shot’s independent effect, its central public-facing claim cannot reliably determine whether the reported protection came from the updated vaccine itself, prior natural immunity, older vaccine doses, or overlapping hybrid immunity.
For many critics, this is a profound scientific and ethical breach in which major public health institutions advanced conclusions that could significantly mislead the public, policymakers, and medical professionals while presenting deeply confounded observational data as meaningful evidence of vaccine-specific benefit.
Follow us on Instagram @realjonfleetwood & Twitter/X @JonMFleetwood.
If you value this reporting, consider upgrading to a paid subscription.
For advertising & sponsorship opportunities, contact us by clicking below.
They must've read the book How To Lie With Statistics.
The experts knew what they were doing
They choose their cohorts carefully
One group was all the recently infected (within one month)
And the placebo group were the vaccinated 6 months or more - since that predisposes majority of them to reinfection more than the non vaxed
It’s not rockets science
Somebody should dig around and find the complete study - more often than not the cohort criteria selection is usually found in the “supplementals” of papers
And if you find it , we can prove the extent of the fraud exposed here
Even without this , this ludicrous absurdity disguised as a paper - if truly referenced by federal and health officials to push *legal medical advice* will open both up for some serious class action litigation
Call you lawyers , and let’s all get some 🤑
And some 4 year old justice ofcourse 😧🤣🤣